Ownership history in Twin Tree Management, LP Β· 12 quarters on record
This page tracks every 13F SEC filing in which Twin Tree Management, LP reported a position in SUMMIT THERAPEUTICS INC (SMMT). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price β sourced directly from SEC EDGAR 13F filings.
π Twin Tree Management, LP underperformed the S&P 500 by β8.1% annually on this SMMT position. Timing score: 50% (5/10 decisions correct). Average cost basis: $19.57. Maximum drawdown during holding period: β18.5%.
β Significantly underperformed the S&P 500 by 8.1% ann.
10 quarters analyzed
β‘οΈ Neutral timing β roughly coin-flip accuracy on add/trim calls.
5 of 10 add/trim decisions correct
Best entry: $17.84 (2024 Q4) Β· Worst: $21.90 (2024 Q3)
π No drawdown exceeding 20% during the holding period β exceptionally stable.
4 adds Β· 8 trims. Bought during 1 of 2 down-price quarters. π Predominantly trimming β distribution phase.
βοΈ Portfolio weight has remained relatively stable β conviction maintained.
Currently 0.0% of portfolio
β Based on quarterly 13F SEC filings and end-of-quarter closing prices. Timing score = accuracy of add/trim decisions vs next-quarter price direction. Alpha = mean quarterly excess return Γ 4 (annualised). Not investment advice.
As of 2025 Q4 β sorted by position size